Ads
related to: SARS-CoV-2- FAQs
Read Frequently Asked Questions
Available at the Official HCP Site.
- Mechanism of Action
Learn About a Potential Treatment
Option for SARS-CoV-2 Infection.
- Dosing Information
Learn About Dosing Info
at the Official Physician Site.
- Support for Patients
Find Resources for Your Patients
During their Treatment.
- FAQs
Search results
COVID lab leak theory resurfaces after controversial new study
Newsweek· 4 days agoFour years on from the COVID-19 pandemic, the origin of the SARS-CoV-2 virus is still contested. The...
How Often Should Immunocompromised People Get a COVID Booster?
MedPage Today· 1 day agoPreventing SARS-CoV-2 infection in immunocompromised people hasn't gotten any easier as the pandemic...
Mutations do not predict the severity of current variants of SARS-CoV-2, finds study
Medical Xpress· 19 hours agoWhen first identified, omicron offshoots BA.2.86 and its close relative JN.1 raised significant public health concerns. There was some speculation that large numbers of new ...
New study reveals insights into COVID-19 antibody response durability
Medical Xpress· 15 hours agoLong-lived plasma cells are responsible for durable antibody responses that persist for decades...
Revive Therapeutics To Submit Type C Meeting Request with FDA for Bucillamine to Treat Long COVID
Morningstar· 42 minutes agoThe Company expects to submit the Type C meeting request by next week.
Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants, study finds
Medical Xpress· 5 days agoIn the study published in Immunity, the researchers analyzed antibody responses in people infected with or vaccinated against the relatively new SARS-CoV
New Precision Drug Candidate Developed Against COVID Virus
Technology Networks· 5 days agoAlthough COVID-19 has faded from the headlines, SARS-CoV-2 – the coronavirus behind the pandemic –...
...Publishes Data from Phase II Trial for LSALT Peptide Targeting Organ Inflammation in Hospitalized...
Digital Journal· 1 day agoPhase II findings previously disclosed support dipeptidase-1 (DPEP-1) as a relevant therapeutic target for diseases of the lung, kidneys and liver where inflammation plays a major role. New ...
COVID-19: Protecting High-Risk Patients
Medscape· 4 days agoAccess to the latest vaccine should be supported by proactive measures by physicians and health authorities to ensure patients are aware of the risks of ...
Report: China’s research on SARS-CoV-2 is focused on military use
World Tribune· 6 days agoDid anyone regard the work at Wuhan Institute of Virology as benefiting the health of the global...
Ad
related to: SARS-CoV-2